HHM Global
Click here to subscribe to our newsletter
Industry Insights

Haemonetics Vivasure Acquisition Reaches Valuation of €185M

Haemonetics Vivasure acquisition values arterial closure device maker at up to €185M, strengthening the Haemonetics position in large-bore closure procedures.

READ MORE


Novartis Plans its Fourth US Radioligand Therapy Facility

Novartis has confirmed its plans for a fourth US radioligand therapy – RLT manufacturing setup at Florida in its $23bn US investment announced in 2025.

READ MORE

Medtronic Wins FDA Clearance for MiniMed Go Smart MDI System

Medtronic has secured FDA clearance for its MiniMed Go smart MDI system, integrating InPen and Abbott’s Instinct sensor to support insulin injection users.

READ MORE


Natera-NVIDIA AI Collaboration Expands Precision Medicine

Natera-NVIDIA AI collaboration aims to scale multimodal foundation models using datasets to improve diagnostics, oncology research, precision medicine tools.

READ MORE

Tempus-NYU Langone Collaboration Advances Precision Oncology

Tempus-NYU Langone collaboration supports molecular profiling and longitudinal cancer research to improve diagnostics, treatment, precision oncology results.

READ MORE


OpenAI Torch Acquisition Adds Healthcare Startup to Fold

OpenAI Torch acquisition brings health-care startup Torch into OpenAI for about $60 million, expanding its push into connected medical data and health AI tools

READ MORE


Advertising:

sunnyroger@hhmglobal.com
Phone: + 91 84476 12124

If you like to receive our latest Media Pack 2025 / Editorial Calender please click here

 

For the latest visit: www.hhmglobal.com

HHM Global